Nuvelo, Orchid, Illumina, Oscient Among 26 Additions to Nasdaq Biotech Index

May 18, 2004

NEW YORK, May 18 (GenomeWeb News) - Several genomics companies, including Nuvelo, Orchid, Illumina, and Oscient (formerly Genome Therapeutics), were among 26 securities added to the Nasdaq Biotechnology Index yesterday.

The change in the index will become effective with the market open next Monday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Sharing, But Kinda Sorta

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

This Week in Science

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

Structural Biologist Leads India's CSIR

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

Upward of One Hundred

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Main menu